Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Long QT Syndrome | 8 | 2021 | 1047 | 1.98 | Why? |
Arrhythmias, Cardiac | 8 | 2020 | 2510 | 1.41 | Why? |
Defibrillators, Implantable | 6 | 2019 | 624 | 1.13 | Why? |
Electrocardiography | 10 | 2021 | 3957 | 1.08 | Why? |
Heart Arrest | 4 | 2018 | 1239 | 1.05 | Why? |
Cardiology Service, Hospital | 2 | 2020 | 602 | 1.01 | Why? |
Electrophysiologic Techniques, Cardiac | 4 | 2020 | 396 | 0.94 | Why? |
Anorexia Nervosa | 2 | 2019 | 103 | 0.85 | Why? |
Ethics, Institutional | 1 | 2020 | 53 | 0.81 | Why? |
Heart Rate | 6 | 2021 | 1527 | 0.77 | Why? |
Electrocardiography, Ambulatory | 1 | 2021 | 204 | 0.76 | Why? |
Diagnostic Techniques, Cardiovascular | 1 | 2020 | 144 | 0.75 | Why? |
Cardiovascular Surgical Procedures | 1 | 2020 | 281 | 0.64 | Why? |
Heart Conduction System | 2 | 2017 | 266 | 0.63 | Why? |
Wearable Electronic Devices | 2 | 2021 | 694 | 0.62 | Why? |
Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.60 | Why? |
Prosthesis-Related Infections | 1 | 2018 | 302 | 0.56 | Why? |
Cardiovascular Diseases | 7 | 2020 | 11497 | 0.55 | Why? |
NAV1.5 Voltage-Gated Sodium Channel | 3 | 2018 | 19 | 0.54 | Why? |
Pacemaker, Artificial | 1 | 2018 | 431 | 0.53 | Why? |
Syncope | 4 | 2017 | 238 | 0.53 | Why? |
Cardiac Rehabilitation | 1 | 2020 | 525 | 0.53 | Why? |
Genetic Testing | 1 | 2017 | 395 | 0.52 | Why? |
Patient Care Management | 3 | 2020 | 1514 | 0.52 | Why? |
Cardiology | 6 | 2020 | 2873 | 0.49 | Why? |
Risk Management | 1 | 2020 | 1044 | 0.47 | Why? |
Stroke Volume | 3 | 2018 | 2153 | 0.46 | Why? |
Death, Sudden, Cardiac | 5 | 2019 | 522 | 0.46 | Why? |
Safety Management | 1 | 2020 | 1093 | 0.45 | Why? |
Tachycardia, Ventricular | 3 | 2019 | 251 | 0.44 | Why? |
Telerehabilitation | 1 | 2020 | 736 | 0.44 | Why? |
KCNQ1 Potassium Channel | 1 | 2009 | 10 | 0.41 | Why? |
Canada | 6 | 2020 | 6018 | 0.38 | Why? |
American Heart Association | 4 | 2020 | 347 | 0.37 | Why? |
Health Care Costs | 1 | 2016 | 1007 | 0.36 | Why? |
Catheter Ablation | 4 | 2020 | 438 | 0.36 | Why? |
Societies, Medical | 5 | 2020 | 6907 | 0.32 | Why? |
North America | 2 | 2020 | 1400 | 0.29 | Why? |
Ritonavir | 1 | 2020 | 4212 | 0.28 | Why? |
Azithromycin | 1 | 2020 | 3943 | 0.28 | Why? |
Models, Organizational | 2 | 2020 | 908 | 0.27 | Why? |
Equipment Failure | 2 | 2018 | 197 | 0.24 | Why? |
Brugada Syndrome | 2 | 2021 | 98 | 0.24 | Why? |
Cardiac Electrophysiology | 2 | 2020 | 239 | 0.23 | Why? |
Advisory Committees | 2 | 2018 | 1418 | 0.23 | Why? |
Heredity | 1 | 2021 | 37 | 0.22 | Why? |
Action Potentials | 3 | 2018 | 368 | 0.22 | Why? |
Pneumonia, Viral | 10 | 2020 | 243684 | 0.22 | Why? |
Genetic Predisposition to Disease | 2 | 2021 | 4027 | 0.22 | Why? |
Coronavirus Infections | 10 | 2020 | 253789 | 0.21 | Why? |
Pandemics | 11 | 2020 | 389249 | 0.21 | Why? |
Electric Countershock | 2 | 2018 | 284 | 0.21 | Why? |
Referral and Consultation | 1 | 2016 | 4816 | 0.21 | Why? |
Organizational Innovation | 2 | 2020 | 2468 | 0.20 | Why? |
Bacitracin | 1 | 2018 | 17 | 0.20 | Why? |
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2019 | 56 | 0.19 | Why? |
Cefazolin | 1 | 2018 | 31 | 0.19 | Why? |
Infection Control | 4 | 2020 | 23131 | 0.19 | Why? |
Cardiac Conduction System Disease | 1 | 2018 | 44 | 0.18 | Why? |
British Columbia | 2 | 2018 | 512 | 0.18 | Why? |
Calcium Channels, L-Type | 1 | 2017 | 15 | 0.18 | Why? |
Tachycardia, Supraventricular | 1 | 2018 | 52 | 0.18 | Why? |
Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 16 | 0.18 | Why? |
Phenotype | 2 | 2021 | 4037 | 0.17 | Why? |
Predictive Value of Tests | 5 | 2021 | 9537 | 0.17 | Why? |
Channelopathies | 1 | 2017 | 12 | 0.17 | Why? |
Anticarcinogenic Agents | 1 | 2017 | 25 | 0.17 | Why? |
Delivery of Health Care | 2 | 2020 | 15909 | 0.17 | Why? |
Ventricular Fibrillation | 1 | 2018 | 126 | 0.17 | Why? |
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.16 | Why? |
Registries | 1 | 2017 | 12327 | 0.16 | Why? |
Equipment Design | 4 | 2021 | 3095 | 0.16 | Why? |
Critical Care | 1 | 2020 | 14081 | 0.16 | Why? |
Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.16 | Why? |
Leadership | 2 | 2020 | 2241 | 0.16 | Why? |
Polymorphism, Single Nucleotide | 1 | 2009 | 3607 | 0.15 | Why? |
Hydroxychloroquine | 1 | 2020 | 12447 | 0.15 | Why? |
Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.15 | Why? |
Cardiac Resynchronization Therapy | 1 | 2018 | 191 | 0.15 | Why? |
Risk Assessment | 8 | 2020 | 25439 | 0.15 | Why? |
Vancomycin | 1 | 2018 | 328 | 0.15 | Why? |
Humans | 42 | 2021 | 930598 | 0.15 | Why? |
Cross-Over Studies | 1 | 2018 | 867 | 0.15 | Why? |
Survivors | 2 | 2018 | 2619 | 0.15 | Why? |
Genetic Association Studies | 1 | 2018 | 559 | 0.14 | Why? |
Atrial Fibrillation | 2 | 2019 | 2320 | 0.13 | Why? |
Health Services | 1 | 2020 | 765 | 0.13 | Why? |
Cardiomyopathies | 2 | 2017 | 997 | 0.12 | Why? |
Consensus | 4 | 2020 | 6345 | 0.12 | Why? |
Calcium | 1 | 2017 | 708 | 0.12 | Why? |
Costs and Cost Analysis | 1 | 2016 | 694 | 0.12 | Why? |
Drug Administration Schedule | 1 | 2018 | 2324 | 0.11 | Why? |
Mutation, Missense | 1 | 2017 | 863 | 0.11 | Why? |
Ventricular Function, Left | 2 | 2018 | 1555 | 0.11 | Why? |
Feasibility Studies | 1 | 2021 | 3467 | 0.11 | Why? |
Cardiovascular Agents | 1 | 2017 | 663 | 0.11 | Why? |
Exercise Test | 1 | 2017 | 911 | 0.10 | Why? |
Regional Medical Programs | 1 | 2009 | 15 | 0.10 | Why? |
Cluster Analysis | 1 | 2018 | 3001 | 0.10 | Why? |
Patient Selection | 3 | 2020 | 4560 | 0.10 | Why? |
Coronary Vessels | 1 | 2017 | 914 | 0.10 | Why? |
Male | 14 | 2021 | 367725 | 0.10 | Why? |
Cardiovascular System | 1 | 2017 | 750 | 0.09 | Why? |
Female | 13 | 2021 | 380317 | 0.09 | Why? |
Gain of Function Mutation | 2 | 2018 | 54 | 0.09 | Why? |
Heart Defects, Congenital | 1 | 2017 | 933 | 0.09 | Why? |
Betacoronavirus | 7 | 2020 | 204454 | 0.09 | Why? |
Middle Aged | 11 | 2021 | 270681 | 0.09 | Why? |
Adult | 10 | 2021 | 244371 | 0.09 | Why? |
Time Factors | 3 | 2021 | 31397 | 0.08 | Why? |
Monitoring, Physiologic | 1 | 2018 | 1956 | 0.08 | Why? |
Heart Failure | 2 | 2018 | 6638 | 0.08 | Why? |
Prospective Studies | 3 | 2021 | 43301 | 0.08 | Why? |
Cardiopulmonary Resuscitation | 1 | 2019 | 1876 | 0.08 | Why? |
Loss of Function Mutation | 2 | 2018 | 244 | 0.08 | Why? |
Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
Atrial Flutter | 1 | 2007 | 143 | 0.07 | Why? |
Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
Risk Factors | 10 | 2019 | 71621 | 0.07 | Why? |
Follow-Up Studies | 3 | 2019 | 17020 | 0.07 | Why? |
Thromboembolism | 1 | 2017 | 2101 | 0.07 | Why? |
Blood Coagulation | 1 | 2017 | 2768 | 0.07 | Why? |
Reproducibility of Results | 1 | 2021 | 11304 | 0.07 | Why? |
Algorithms | 2 | 2018 | 7346 | 0.07 | Why? |
Occupational Health | 1 | 2020 | 3965 | 0.06 | Why? |
Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
Clinical Decision-Making | 1 | 2017 | 3755 | 0.06 | Why? |
Ontario | 1 | 2009 | 1966 | 0.06 | Why? |
Anti-Arrhythmia Agents | 1 | 2005 | 325 | 0.06 | Why? |
Elective Surgical Procedures | 1 | 2020 | 5338 | 0.06 | Why? |
Mass Screening | 2 | 2020 | 8005 | 0.06 | Why? |
Morbidity | 2 | 2018 | 1426 | 0.06 | Why? |
Case-Control Studies | 1 | 2019 | 17671 | 0.05 | Why? |
Epicardial Mapping | 1 | 2019 | 12 | 0.05 | Why? |
Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
Ion Channel Gating | 1 | 2017 | 22 | 0.04 | Why? |
Pulmonary Veins | 1 | 2019 | 146 | 0.04 | Why? |
Comorbidity | 2 | 2020 | 34796 | 0.04 | Why? |
Cardiac Imaging Techniques | 1 | 2020 | 357 | 0.04 | Why? |
Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.04 | Why? |
Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
Models, Cardiovascular | 1 | 2017 | 153 | 0.04 | Why? |
Health Surveys | 1 | 2008 | 2841 | 0.04 | Why? |
Signal Processing, Computer-Assisted | 1 | 2018 | 193 | 0.04 | Why? |
Anticoagulants | 1 | 2017 | 9563 | 0.04 | Why? |
Sodium | 1 | 2017 | 309 | 0.04 | Why? |
Organizational Policy | 1 | 2020 | 694 | 0.04 | Why? |
Return to Work | 1 | 2020 | 579 | 0.03 | Why? |
Aged | 5 | 2018 | 215776 | 0.03 | Why? |
Treatment Outcome | 5 | 2019 | 51732 | 0.03 | Why? |
Adrenergic beta-Agonists | 1 | 2012 | 93 | 0.03 | Why? |
Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
Retrospective Studies | 3 | 2019 | 105322 | 0.03 | Why? |
United States | 4 | 2020 | 46150 | 0.03 | Why? |
Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.03 | Why? |
Epinephrine | 1 | 2012 | 323 | 0.02 | Why? |
Adolescent | 1 | 2019 | 86841 | 0.02 | Why? |
Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
Hospitalization | 1 | 2018 | 54280 | 0.02 | Why? |
Incidence | 1 | 2009 | 25622 | 0.02 | Why? |
Age Factors | 2 | 2018 | 21039 | 0.02 | Why? |
Guideline Adherence | 1 | 2019 | 2309 | 0.02 | Why? |
Asymptomatic Diseases | 1 | 2018 | 3444 | 0.02 | Why? |
Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.02 | Why? |
Young Adult | 2 | 2018 | 93724 | 0.02 | Why? |
Child | 3 | 2018 | 70012 | 0.02 | Why? |
HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
Prognosis | 2 | 2017 | 32490 | 0.02 | Why? |
Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.02 | Why? |
Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
Dose-Response Relationship, Drug | 1 | 2012 | 3776 | 0.01 | Why? |
Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
Telemedicine | 2 | 2020 | 25032 | 0.01 | Why? |
Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
Infant | 1 | 2018 | 30274 | 0.01 | Why? |
Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
Evidence-Based Medicine | 1 | 2005 | 3228 | 0.01 | Why? |
Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Primary Health Care | 1 | 2005 | 4839 | 0.01 | Why? |
Practice Patterns, Physicians' | 1 | 2005 | 4927 | 0.01 | Why? |
Clinical Trials as Topic | 1 | 2005 | 7330 | 0.00 | Why? |
Prevalence | 1 | 2005 | 25773 | 0.00 | Why? |
Krahn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(108)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_